FDA, European Drug Agency Collaborate on Clinical Trial Oversight

被引：0

|

作者：

不详

机构：

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2009年 / 302卷 / 16期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：1740 / 1740

页数：1

相关论文

共 50 条

[1] FDA enhances oversight of postmarket drug safety
Reactions Weekly, 2012, 1400 (1) : 2 - 2
[2] FDA bioproduct oversight shifts to drug division
Wong, JF
GENETIC ENGINEERING NEWS, 2002, 22 (17): : 55 - +
[3] FDA Realigns Drug Inspection and Manufacturing Oversight
Wechsler, Jill
BIOPHARM INTERNATIONAL, 2014, 27 (12) : 8 - +
[4] European drug agency backtracks on plan to give researchers access to clinical trial reports
Torjesen, Ingrid
BMJ-BRITISH MEDICAL JOURNAL, 2014, 348
[5] NCI, FDA to collaborate on speeding up drug discovery
Arnold, K
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (16) : 1192 - 1192
[6] FDA Oversight of Cell Therapy Clinical Trials
Au, Patrick
Hursh, Deborah A.
Lim, Agnes
Moos, Malcolm C., Jr.
Oh, Steven S.
Schneider, Bruce S.
Witten, Celia M.
SCIENCE TRANSLATIONAL MEDICINE, 2012, 4 (149)
[7] European drug agency sets out plans to publish clinical trial data from 2014
Watson, Rory
BRITISH MEDICAL JOURNAL, 2012, 345
[8] Overhauling oversight—European drug legislation
Lincoln Tsang
Nature Biotechnology, 2005, 23 : 1050 - 1053
[9] FDA OVERSIGHT OF CLINICAL TRIALS The US FDA and regulatory free fall
Wilson, Mark
BMJ-BRITISH MEDICAL JOURNAL, 2023, 380
[10] Overhauling oversight - European drug legislation
Tsang, L
NATURE BIOTECHNOLOGY, 2005, 23 (09) : 1050 - 1053

← 1 2 3 4 5 →